Association of Amyloid and Tau With Cognition in Preclinical Alzheimer DiseaseBernard Hanseeuw, Keith A. Johnson, Rebecca A. Betensky et al.|JAMA Neurology|2019Cited by 876
Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older AdultsRachel F. Buckley, Reisa A. Sperling, Elizabeth C. Mormino et al.|JAMA Neurology|2019Cited by 377
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group RecommendationBruno Dubois, Giovanni B. Frisoni, Nicolas Villain et al.|JAMA Neurology|2024Cited by 355
Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal IndividualsAaron P. Schultz, Reisa A. Sperling, Jasmeer P. Chhatwal et al.|Journal of Neuroscience|2017Cited by 347
Sex, amyloid, and <i>APOE</i> ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well‐characterized cohortsRachel F. Buckley, Elizabeth C. Mormino, Rebecca E. Amariglio et al.|Alzheimer s & Dementia|2018Cited by 289